Cargando…

Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue

BACKGROUND: Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons involved are well represented. This can be achieved by stakeholder engagement...

Descripción completa

Detalles Bibliográficos
Autores principales: Canella, Claudia, Mikolasek, Michael, Rostock, Matthias, Guckenberger, Matthias, Jenewein, Josef, Linka, Esther, Six, Claudia, Stoll, Sarah, Stupp, Roger, Witt, Claudia M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245792/
https://www.ncbi.nlm.nih.gov/pubmed/32448184
http://dx.doi.org/10.1186/s12885-020-06858-6
_version_ 1783537818064125952
author Canella, Claudia
Mikolasek, Michael
Rostock, Matthias
Guckenberger, Matthias
Jenewein, Josef
Linka, Esther
Six, Claudia
Stoll, Sarah
Stupp, Roger
Witt, Claudia M.
author_facet Canella, Claudia
Mikolasek, Michael
Rostock, Matthias
Guckenberger, Matthias
Jenewein, Josef
Linka, Esther
Six, Claudia
Stoll, Sarah
Stupp, Roger
Witt, Claudia M.
author_sort Canella, Claudia
collection PubMed
description BACKGROUND: Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons involved are well represented. This can be achieved by stakeholder engagement. In this paper, different key stakeholders’ experiences and views on the feasibility of treating CRF in the context of supportive care in hospital environments are analyzed. METHOD: In a qualitative study with the aim of developing an integrative treatment program for CRF, a total of 22 stakeholders (6 medical oncologists, 5 nurses, 9 patients, 1 patient family member, 1 representative of the Swiss Cancer League) were interviewed either in a face-to-face (n = 12) or focus group setting (n = 2). For data analyses, the method of qualitative content analysis was used. RESULTS: The stakeholders referred to different contextual factors when talking about the feasibility of treating CRF in the context of supportive care in hospital environments. These included: assessment, reporting and information; treatability; attitude; infrastructure, time-management, costs and affordability; and integrative approach. CONCLUSIONS: Key factors of a feasible treatment approach to CRF are a coherent, cost effective integrative treatment program facilitated by an interdisciplinary team of health care providers. Furthermore, the treatment approach should be patient orientated, adopting an individualized approach. The major challenges of making the integrative treatment program feasible for CRF are resources and interprofessional collaboration.
format Online
Article
Text
id pubmed-7245792
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-72457922020-06-01 Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue Canella, Claudia Mikolasek, Michael Rostock, Matthias Guckenberger, Matthias Jenewein, Josef Linka, Esther Six, Claudia Stoll, Sarah Stupp, Roger Witt, Claudia M. BMC Cancer Research Article BACKGROUND: Although cancer-related fatigue (CRF) has gained increased attention in the past decade, therapy remains a challenge. Treatment programs are more likely to be effective if the needs and interests of the persons involved are well represented. This can be achieved by stakeholder engagement. In this paper, different key stakeholders’ experiences and views on the feasibility of treating CRF in the context of supportive care in hospital environments are analyzed. METHOD: In a qualitative study with the aim of developing an integrative treatment program for CRF, a total of 22 stakeholders (6 medical oncologists, 5 nurses, 9 patients, 1 patient family member, 1 representative of the Swiss Cancer League) were interviewed either in a face-to-face (n = 12) or focus group setting (n = 2). For data analyses, the method of qualitative content analysis was used. RESULTS: The stakeholders referred to different contextual factors when talking about the feasibility of treating CRF in the context of supportive care in hospital environments. These included: assessment, reporting and information; treatability; attitude; infrastructure, time-management, costs and affordability; and integrative approach. CONCLUSIONS: Key factors of a feasible treatment approach to CRF are a coherent, cost effective integrative treatment program facilitated by an interdisciplinary team of health care providers. Furthermore, the treatment approach should be patient orientated, adopting an individualized approach. The major challenges of making the integrative treatment program feasible for CRF are resources and interprofessional collaboration. BioMed Central 2020-05-24 /pmc/articles/PMC7245792/ /pubmed/32448184 http://dx.doi.org/10.1186/s12885-020-06858-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Canella, Claudia
Mikolasek, Michael
Rostock, Matthias
Guckenberger, Matthias
Jenewein, Josef
Linka, Esther
Six, Claudia
Stoll, Sarah
Stupp, Roger
Witt, Claudia M.
Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title_full Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title_fullStr Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title_full_unstemmed Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title_short Experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
title_sort experiences and views of different key stakeholders on the feasibility of treating cancer-related fatigue
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245792/
https://www.ncbi.nlm.nih.gov/pubmed/32448184
http://dx.doi.org/10.1186/s12885-020-06858-6
work_keys_str_mv AT canellaclaudia experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT mikolasekmichael experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT rostockmatthias experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT guckenbergermatthias experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT jeneweinjosef experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT linkaesther experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT sixclaudia experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT stollsarah experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT stupproger experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue
AT wittclaudiam experiencesandviewsofdifferentkeystakeholdersonthefeasibilityoftreatingcancerrelatedfatigue